Evaluating the Suitability of Using Rat Models for Preclinical Efficacy and Side Effects with Inhaled Corticosteroids Nanosuspension Formulations
<p>Abstract</p> <p>Inhaled corticosteroids (ICS) are often prescribed as first-line therapy for patients with asthma Despite their efficacy and improved safety profile compared with oral corticosteroids, the potential for systemic side effects continues to cause concern. In order t...
Main Authors: | Chiang Po-Chang, Hu Yiding, Blom Jason, Thompson David |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2010-01-01
|
Series: | Nanoscale Research Letters |
Subjects: | |
Online Access: | http://dx.doi.org/10.1007/s11671-010-9597-y |
Similar Items
-
Study on Formulation, in vivo Exposure, and Passive Targeting of Intravenous Itraconazole Nanosuspensions
by: Qi Yuan, et al.
Published: (2019-03-01) -
Improvement of the Solubility and Dissolution Characteristics of Risperidone via Nanosuspension Formulations
by: Hayder Emad, et al.
Published: (2022-06-01) -
Pharmacokinetic evaluation of a 1,3-dicyclohexylurea nanosuspension formulation to support early efficacy assessment
by: Chiang Po-Chang, et al.
Published: (2007-01-01) -
Development of nintedanib nanosuspension for inhaled treatment of experimental silicosis
by: Luisa Helena Andrade da Silva, et al.
Published: (2023-03-01) -
Preparation and evaluation of famotidine nanosuspension
by: Marwa M. Malik, et al.
Published: (2018-12-01)